Literature DB >> 20123555

Dopaminergic function and progression of Parkinson's disease: PET findings.

G Biju1, R de la Fuente-Fernández.   

Abstract

Recent PET studies in Parkinson's disease (PD) have shown that the progression of neurodegeneration follows an exponential decay pattern. Most of the damage to the nigrostriatal dopamine system occurs during the presymptomatic phase of the disease and the first few years following symptom onset. The progressive loss of dopaminergic neurons is accompanied by several functional adaptive changes in surviving nerve terminals, which lead to increased dopamine turnover and raise the risk of treatment-related motor complications. Younger PD patients seem to have more efficient compensatory mechanisms and a slower rate of progression of neurodegeneration. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20123555     DOI: 10.1016/S1353-8020(09)70833-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

Review 1.  CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.

Authors:  Alessandro Stefani; Livia Brusa; Enrica Olivola; Mariangela Pierantozzi; Alessandro Martorana
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

2.  The diagnostic value of minor salivary gland biopsy in clinically diagnosed patients with Parkinson's disease: comparison with DAT PET scans.

Authors:  Liyan Gao; Huimin Chen; Xin Li; Fangfei Li; Qiaohong Ou-Yang; Tao Feng
Journal:  Neurol Sci       Date:  2015-03-28       Impact factor: 3.307

3.  The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.

Authors:  Nevein Ibrahim; Joanna Kusmirek; Aaron F Struck; John M Floberg; Scott B Perlman; Catherine Gallagher; Lance T Hall
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-01-28

Review 4.  How to design PET experiments to study neurochemistry: application to alcoholism.

Authors:  Evan D Morris; Molly V Lucas; J Ryan Petrulli; Kelly P Cosgrove
Journal:  Yale J Biol Med       Date:  2014-03-05

5.  Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT.

Authors:  Victor Comte; Hugo Schmutz; David Chardin; Fanny Orlhac; Jacques Darcourt; Olivier Humbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-14       Impact factor: 10.057

6.  Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.

Authors:  Lior Greenbaum; Mordechai Lorberboym; Eldad Melamed; Amihai Rigbi; Yael Barhum; Yoav Kohn; Alexander Khlebtovsky; Bernard Lerer; Ruth Djaldetti
Journal:  Front Neurosci       Date:  2013-04-15       Impact factor: 4.677

7.  Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity.

Authors:  Chris Rudyk; Darcy Litteljohn; Shuaib Syed; Zach Dwyer; Shawn Hayley
Journal:  Neurobiol Stress       Date:  2015-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.